LUMI PRO Eyes PN Skin Booster | 1x1ml per pack | Polynucleotide (PN) 5 mg/ml
LUMI-PRO
Injectable skin booster
Under-eye polynucleotide (PN) skin booster
Certifications
Professional Use injectable skin booster marketed in the UK/EU for under Eye rejuvenation via authorised aesthetic wholesalers.
Manufactured under medical Aesthetic quality systems; practitioners should confirm device classification, CE/UKCA marking and regulatory status from packaging and technical documentation.
Use restricted to trained healthcare or aesthetic professionals in line with local regulations governing injectable aesthetic treatments.
Professional Use injectable skin booster marketed in the UK/EU for under Eye rejuvenation via authorised aesthetic wholesalers.
Manufactured under medical Aesthetic quality systems; practitioners should confirm device classification, CE/UKCA marking and regulatory status from packaging and technical documentation.
Use restricted to trained healthcare or aesthetic professionals in line with local regulations governing injectable aesthetic treatments.
Under-eye polynucleotide (PN) skin booster
Description
LUMI-PRO Eyes PN Skin Booster is a targeted under-eye injectable designed to treat dark circles, puffiness and fine wrinkles in the delicate periocular area. Each 1 ml pre-filled syringe contains 5 mg/ml of polynucleotides (PN), purified DNA fragments that stimulate cellular repair and collagen production. The lightweight, non-volumising solution deeply hydrates and revitalises the under-eye skin, improving tone, texture, elasticity and overall radiance without altering natural facial contours. Intended for professional use, LUMI-PRO Eyes offers a clinically effective, minimally invasive option for patients seeking a refreshed, more youthful under-eye appearance.
Bnefits
Specifically formulated for the delicate under-eye and periocular area.
Contains 5 mg/ml of polynucleotides (PN) to stimulate cell repair and collagen production.
Visibly reduces dark under-eye circles and puffiness.
Smooths and minimises fine lines and wrinkles without adding volume.
Improves skin tone and texture for a brighter, more even under-eye area.
Restores elasticity and firmness by supporting collagen and elastin synthesis.
Provides deep, long-lasting hydration with a lightweight, non-bulking feel.
Delivers natural-looking, gradual rejuvenation with minimal downtime.
Suitable as a standalone biostimulatory treatment or in combination with other aesthetic procedures.
Professional-use product offering a targeted, non-surgical solution for tired, ageing or dehydrated under-eyes.
Indications
Dark under-eye circles related to skin quality and microvascular changes.
Under-eye puffiness and mild under-eye bags.
Fine lines and wrinkles around the eyes, including crow’s feet.
Sagging, crepey or lax under-eye skin.
Dull, dehydrated or tired-looking periocular skin.
Patients seeking subtle, natural under-eye rejuvenation without volumising filler.
Adjunctive treatment in a broader periocular anti-ageing protocol as determined by the practitioner.
Other standard buffering components as listed in the internal Instructions for Use.
Formulation
Sterile, clear aqueous solution containing polynucleotides (PN) for intradermal use.
Polynucleotide concentration: 5 mg/ml in a 1 ml pre-filled syringe.
Non-crosslinked, non-hyaluronic acid formulation focused on biostimulation and skin quality improvement rather than volumetric filling.
Designed for micro-deposit/mesotherapy-style injection into the superficial to mid-dermis of the under-eye area.
Packaging
Each retail unit contains 1 x 1 ml pre-filled sterile syringe of LUMI-PRO Eyes PN Skin Booster.
Syringe supplied in a protective blister tray within branded outer carton.
Outer packaging labelled with product name, strength (PN 5 mg/ml), volume (1 ml), batch/lot number, expiry date and basic product information.
Intended for single-patient, single-use; any remaining product must be discarded after treatment.
Usage
For professional use only and must be administered by suitably trained healthcare or aesthetic practitioners.
Indicated for the under-eye/periocular region; injections should be placed in the superficial to mid-dermis using micro-deposits, serial puncture or mesotherapy-style techniques, avoiding intravascular injection.
Before treatment, perform a full medical history, under-eye assessment and informed consent; discuss realistic expectations and potential risks.
Cleanse and disinfect the periocular area thoroughly; maintain strict aseptic technique with sterile gloves, needles and equipment.
Use fine-gauge needles (commonly 30G or similar) to deliver small aliquots evenly under the eye, staying a safe distance from the lash line and orbital rim.
Most protocols recommend a course of 3–4 treatment sessions spaced approximately 2–3 weeks apart, with maintenance sessions every few months depending on individual needs and response.
After treatment, advise patients to avoid touching or rubbing the area, applying makeup for at least 12–24 hours, and to avoid strenuous exercise, alcohol, saunas/steam rooms and direct heat or intense sun exposure for 24–48 hours.
Encourage consistent daily use of a broad-spectrum SPF around the eye area (where appropriate) to protect and maintain results.
Schedule follow-up appointments to review outcomes, address any adverse events and plan ongoing maintenance or combination treatments.
Contraindications
Known hypersensitivity or allergy to polynucleotides, sodium DNA or any other component of the product.
Active skin infection, inflammation or disease in the intended treatment area (e.g. dermatitis, eczema, psoriasis, bacterial or viral infections such as herpes simplex).
History of severe allergic reactions or anaphylaxis to injectable biostimulatory products or similar treatments.
Uncontrolled systemic disease, significant immunosuppression or bleeding/coagulation disorders, unless carefully assessed and approved by a qualified clinician.
Pregnancy and breastfeeding, as elective aesthetic injectables are generally avoided due to limited safety data.
Previous periocular surgery, implants or permanent fillers in the treatment area that may increase the risk of complications, unless the procedure is deemed safe by an experienced practitioner.
Any additional contraindications and cautions stated in the manufacturer or distributor’s professional product information and in relevant local clinical guidelines.
Adverse Effects
Common transient reactions at the injection sites including redness, mild swelling, tenderness, superficial bruising, pinpoint bleeding and temporary itching or warmth.
Small papules or bumps at injection points, typically resolving within hours to a few days as the solution disperses.
Occasional post-treatment oedema or mild under-eye puffiness, usually short-lived.
Rare local inflammatory reactions or nodules that may require clinical assessment and management.
Risk of infection if aseptic technique is not followed or if aftercare instructions are not adhered to, potentially presenting with increasing pain, redness, warmth or discharge.
As with any periocular injectable, there is a very small risk of vascular compromise if product is inadvertently injected intravascularly; practitioners must be trained to recognise early warning signs (severe pain, blanching, mottling, visual changes) and initiate emergency protocols.
Possible hypersensitivity or allergic-type responses to one or more components, necessitating prompt clinical review.
Patients should be instructed to seek immediate medical advice if they experience severe or worsening pain, marked discolouration, persistent swelling, visual disturbance or signs of infection.
Storage Conditions
Store in the original packaging in a cool, dry place away from direct sunlight and heat sources.
Maintain within the temperature range specified on the packaging (commonly between 2°C and 25°C); do not freeze.
Keep the syringe in its protective blister until use to maintain sterility and protect from physical damage.
Do not use the product after the expiry date, or if the packaging, syringe or solution appears damaged, discoloured or contains visible particulates.
Keep out of the reach of children and unauthorised persons, in accordance with clinic storage policies for injectable products.
Duration
Supplier guidance and clinical protocols typically recommend a course of 3\u20134 sessions spaced 2\u20133 weeks apart, with results maintained through periodic top-up treatments every 6\u201312 months depending on skin quality, lifestyle and ageing rate. Individual longevity of effect may vary but improvements are generally sustained for several months after a completed course.
Onset
Initial improvements in hydration and brightness may be noticed within days to a few weeks after treatment, with progressive reductions in dark circles, puffiness and fine lines becoming more apparent over a course of sessions as collagen production and tissue repair are stimulated.
